AssetMark Inc
CDMO

AssetMark Inc’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

AssetMark Inc’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-39
Closed – – 1467
2016
Q4 		$0 Buy
+39
New +$91 ﹤0.01% 1407

Other funds holding CDMO

KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
TSP
Tappan Street Partners Chicago, Illinois $35.7M AUM 42.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
BAS
Brown Advisory Securities Baltimore, Maryland $27.3M AUM 10.67% 1-Year Est. Return

AssetMark Inc's CDMO Position: Q1 2017 in Review

AssetMark Inc sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2017, closing a stake of 39 shares.

AssetMark Inc first reported a position in CDMO in Q4 2016 and held it in 1 quarter. The position peaked at $0 in Q4 2016. 61 funds tracked by Wall St. Rank hold CDMO as of Q1 2017.

  • AssetMark Inc reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
  • AssetMark Inc sold 39 Avid Bioservices, Inc. Common Stock shares in Q1 2017.
  • AssetMark Inc first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2016 and held it in 1 quarter.
  • AssetMark Inc's Avid Bioservices, Inc. Common Stock position peaked at $0 in Q4 2016.
  • 61 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2017.

Based on AssetMark Inc's 13F filing for Q1 2017, filed 9 May 2017.